Antipsoriatic anthrones with modulated redox properties. 4. Synthesis and biological activity of novel 9,10-dihydro-1,8-dihydroxy-9-oxo-2- anthracenecarboxylic and -hydroxamic acids

Journal of Medicinal Chemistry

Volumn 40, Issue 17, 1997, Pages 2780-2787

  Müller, Klaus ^a   Prinz, Helge ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

9,10 DIHYDRO 1,8 DIHYDROXY 9 OXO 2 ANTHRACENECARBOXYLIC ACID; 9,10 DIHYDRO 1,8 DIHYDROXY 9 OXO 2 ANTHRACENEHYDROXAMIC ACID; CARBOXYLIC ACID DERIVATIVE; DITHRANOL; HYDROXAMIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CYTOTOXICITY; DRUG SYNTHESIS; ENZYME RELEASE; KERATINOCYTE; LIPID PEROXIDATION; METHYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN DEGRADATION; PSORIASIS;

ANIMALS; ANTIOXIDANTS; ARACHIDONATE 5-LIPOXYGENASE; CARBOXYLIC ACIDS; CATTLE; CELL LINE; HUMANS; HYDROXAMIC ACIDS; HYDROXYL RADICAL; MODELS, CHEMICAL; OXIDATION-REDUCTION; PSORIASIS;

EID: 0000442177     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9701785     Document Type: Article

References (50)

1. For part 3, see: Müller, K.; Huang, H.-S.; Wiegrebe, W. Antipsoriatic anthrones with modulated redox properties. 3. 10-Thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis. J. Med. Chem. 1996, 39, 3132-3138.
2. Kemény, L.; Ruzicka, T.; Braun-Falco, O. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol. 1990, 3, 1-20.
3. Wiegrebe, W.; Müller, K. Treatment of psoriasis with anthrones - chemical principles, biochemical aspects, and approaches to the design of novel derivatives. Skin Pharmacol. 1995, 8, 1-24.
4. Müller, K. Antipsoriatic anthrones: aspects of oxygen radical formation, challenges and prospects. Gen. Pharmacol. 1996, 27, 1325-1335.
5. Müller, K. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals. Biochem. Pharmacol. 1997, 53, in press.
6. Müller, K.; Gürster, D.; Piwek, S.; Wiegrebe, W. Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase. J. Med. Chem. 1993, 36, 4099-4107.
7. Müller, K.; Wiegrebe, W.; Younes, M. Formation of active oxygen species by dithranol, III. Dithranol, active oxygen species and lipid peroxidation in vivo. Arch. Pharm. (Weinheim, Ger.) 1987, 320, 59-66.
8. Miller, D. M.; Buettner, G. R.; Aust, S. D. Transition metals as catalysts of "autoxidation" reactions. Free Radical Biol. Med. 1990, 8, 95-108.
9. Halliwell, B. The biological significance of oxygen-derived species. In Active Oxygen in Biochemistry; Valentine, J. S., Foote, C. S., Greenberg, A., Liebman, J. F., Eds.; Blackie Academic & Professional: London, 1995; pp 313-335.
10. Halliwell, B. Antioxidant characterization. Methodology and mechanism. Biochem. Pharmacol. 1995, 49, 1341-1348.
11. Winterbourn, C. C. Superoxide as an intracellular radical sink. Free Radical Biol. Med. 1993, 14, 85-90.
12. Halliwell, B.; Gutteridge, J. M. C. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 1990, 186, 1-85.
13. Müller, K.; Kappus, H. Hydroxyl radical formation by dithranol. Biochem. Pharmacol. 1988, 37, 4277-4280.
14. Müller, K.; Gürster, D. Hydroxyl radical damage to DNA sugar and model membranes induced by anthralin (dithranol). Biochem. Pharmacol. 1993, 46, 1695-1704.
15. Trenam, C. W.; Blake, D. R.; Morris, C. J. Skin inflammation: reactive oxygen species and the role of iron. J. Invest. Dermatol. 1992, 99, 675-682.
16. Hider, R. C.; Hall, A. D. Clinically useful chelators of tripositive elements. Prog. Med. Chem. 1991, 28, 41-173.
17. Green, E. S. R.; Evans, H.; Rice-Evans, P.; Davies, M. J.; Salah, N.; Rice-Evans, C. The efficacy of monohydroxamates as free radical scavenging agents compared with di-and trihydroxamates. Biochem. Pharmacol. 1993, 45, 357-366.
18. Musser, J. H.; Kreft, A. F. 5-Lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors. J. Med. Chem. 1992, 35, 2501-2524.
19. Corey, E. J.; Cashman, J. R.; Kantner, S. S.; Wright, S. W. Rationally designed, potent competitive inhibitors of leukotriene biosynthesis. J. Am. Chem. Soc. 1984, 106, 1503-1504.
20. Summers, J. B.; Mazdiyasni, H.; Holms, J. H.; Ratajczyk, J. D.; Dyer, R. D.; Carter, G. W. Hydroxamic acid inhibitors of 5-lipoxygenase. J. Med. Chem. 1987, 30, 574-580.
21. Summers, J. B.; Kim, K. H.; Mazdiyasni, H.; Holms, J. H.; Ratajczyk, J. D.; Stewart, A. O.; Dyer, R. D.; Carter, G. W. Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure - activity relationships. J. Med. Chem. 1990, 33, 992-998.
22. Huang, F.-C.; Shoupe, T. S.; Lin, C. J.; Lee, T. D. Y.; Chan, W.-K.; Tan, J.; Schnapper, M.; Suh, J. T.; Gordon, R. J.; Sonnino, P. A.; Sutherland, C. A.; Van Inwegen, R. G.; Coutts, S. M. Differential effects of a series of hydroxamic acid derivatives on 5-lipoxygenase and cyclooxygenase from neutrophils and 12-lipoxygenase from platelets and their in vivo effects on inflammation and anaphylaxis. J. Med. Chem. 1989, 32, 1836-1842.
23. Wright, S. W.; Harris, R. R.; Kerr, J. S.; Green, A. M.; Pinto, D. J.; Bruin, E. M.; Collins, R. J.; Dorow, R. L.; Mantegna, L. R.; Sherk, S. R.; Covington, M. B.; Nurnberg, S. A.; Welch, P. K.; Nelson, M. J.; Magolda, R. L. Synthesis, chemical, and biological properties of vinylogous hydroxamic acids: dual inhibitors of 5-lipoxygenase and IL-1 biosynthesis. J. Med. Chem. 1992, 35, 4061-4068.
24. Ohemeng, K. A.; Appolina, M. A.; Nguyen, V. N.; Schwender, C. F.; Singer, M.; Steber, M.; Ansell, J.; Argentieri, D.; Hageman, W. Synthesis and 5-lipoxygenase inhibitory activities of some novel 2-substituted 5-benzofuran hydroxamic acids. J. Med. Chem. 1994, 37, 3663-3667.
25. Hamer, R. R. L.; Tegeler, J. J.; Kurtz, E. S.; Allen, R. C.; Bailey, S. C.; Elliot, M. E.; Hellyer, L.; Helsley, G. C.; Przekop, P.; Freed, B. S.; White, J.; Martin, L. L. Dibenzoxepinone hydroxylamines and hydroxamic acids: dual inhibitors of cyclooxygenase and 5-lipoxygenase with potent topical antiinflammatory activity. J. Med. Chem. 1996, 39, 246-252.
26. Brooks, C. D. W.; Summers, J. B. Modulators of leukotriene biosynthesis and receptor activation. J. Med. Chem. 1996, 39, 2629-2654.
27. Krohn, K. Synthesis of anthracyclinones by electrophilic and nucleophilic addition to anthraquinones. Tetrahedron 1990, 46, 291-318.
28. Prinz, H.; Müller, K. 2-Anthracenonyl acetic acids as 5-lipoxygenase inhibitors. Arch. Pharm. Pharm. Med. Chem. 1996, 329, 262-266.
29. Hutchins, R. O.; Taffer, I. M. Aqueous polar aprotic solvents. Efficient sources of nucleophilic oxygen. J. Org. Chem. 1983, 48, 1360-1362.
30. Tanzer, H.; Seidel, M.; Wiegrebe, W. Hydrophilic derivatives of dithranol. Arch. Pharm. (Weinheim, Ger.) 1988, 321, 447-449.
31. Müller, K.; Leukel, P.; Ziereis, K.; Gawlik, I. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin - antiproliferative activity and 5-lipoxygenase inhibition. J. Med. Chem. 1994, 37, 1660-1669.
32. Jones, G. H.; Venuti, M. C.; Young, J. M.; Krishna Murthy, D. V.; Loe, B. E.; Simpson, R. A.; Berks, A. H.; Spires, D. A.; Maloney, P. J.; Kruseman, M.; Rouhafza, S.; Kappas, K. C.; Beard, C. C.; Unger, S. H.; Cheung, P. S. Topical nonsteroidal antipsoriatic agents: 1. 1,2,3,4-Tetraoxygenated naphthalene derivatives. J. Med. Chem. 1986, 29, 1504-1511.
33. Venuti, M. C.; Loe, B. E.; Jones, G. H.; Young, J. M. Topical nonsteroidal antipsoriatic drugs. 2. 2,3-(Alkylidenedioxy(naphthalene analogues of lonapalene. J. Med. Chem. 1988, 31, 2132-2136.
34. Batt, D. G.; Maynard, G. D.; Petraitis, J. J.; Shaw, J. E.; Galbraith, W.; Harris, R. R. 2-Substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity. J. Med. Chem. 1990, 33, 360-370.
35. Hammond, M. L.; Zambias, R. A.; Chang, M. N.; Jensen, N. P.; McDonald, J.; Thompson, K.; Boulton, D. A.; Kopka, I. E.; Hand, K. M.; Opas, E. E.; Luell, S.; Bach, T.; Davies, P.; MacIntyre, D. E.; Bonney, R. J.; Humes, J. L. Antioxidant-based inhibitors of leukotriene biosynthesis. The discovery of 6-[1-[2-(hydroxymethyl)phenyl]-1-propen-3-yl]-2,3-dihydro-5-benzofuranol, a potent topical antiinflammatory agent. J. Med. Chem. 1990, 33, 908-918.
36. Winyard, P. G.; Morris, C. J.; Winrow, V. R.; Zaidi, M.; Blake, D. R. Free radical pathways in the inflammatory response. New Comp. Biochem. 1994, 28, 361-383.
37. Braughler, J. M.; Duncan, L. A.; Chase, R. L. The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation. J. Biol. Chem. 1986, 261, 10282-10289.
38. Aust, S. D.; Miller, D. M.; Samokyszyn, V. M. Iron redox reactions and lipid peroxidation. Methods Enzymol. 1990, 186, 457-463.
39. 4 stimulate DNA synthesis in cultured human epidermal keratinocytes. Br. J. Dermatol. 1985, 113, 43-52.
40. 4 and 12-hydroxyeicosatetraenoic acid stimulate epidermal proliferation in vivo in the guinea pig. J. Invest. Dermatol. 1985, 85, 333-334.
41. Janssen-Timmen, U.; Vickers, P. J.; Wittig, U.; Lehmann, W. D.; Stark, H.-J.; Fusening, N. E.; Rosenbach, T.; Rådmark, O.; Samuelsson, B.; Habenicht, A. J. R. Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 6966-6970.
42. Bonnekoh, B.; Farkas, B.; Geisel, J.; Mahrle, G. Lactate dehydrogenase release as an indicator of dithranol-induced membrane injury in cultured human keratinocytes. Arch. Dermatol. Res. 1990, 282, 325-329.
43. Trenam, C. W.; Dabbagh, A. J.; Blake, D. R.; Morris, C. J. The role of iron in an acute model of skin inflammation induced by reactive oxygen species. Br. J. Dermatol. 1992, 126, 250-256.
44. Prinz, H.; Wiegrebe, W.; Müller, K. Synthesis of anthracenones. 1. Sodium dithionite reduction of peri-substituted anthracenediones. J. Org. Chem. 1996, 61, 2853-2856.
45. Stetter, H.; Leinen, H. T. Addition von Aldehyden an aktivierte Doppelbindungen, XXXIII. Synthesen und Reaktionen von ether-und esterhaltigen γ-Diketonen. (Addition of aldehydes to activated double bonds, XXXIII. Syntheses and reactions of γ-dike-tones containing ether-or ester groups.) Chem. Ber. 1983, 116, 254-263.
46. Machleidt, H.; Cohnen, E.; Tschesche, R. Synthesen von D,L-Mevalonsäure-3,5-cyclophosphat und D,L-Mevalonsäure-5-phosphat. (Syntheses of D,L-mevalonic acid 3,5-cyclophosphate and D,L-mevalonic acid 5-phosphate.) Liebigs Ann. Chem. 1962, 655, 70-80.
47. Fujita, I.; Tamura, Y.; Tani, H. ω-Formyl valerates. Japan Patent 70 72,338; Chem. Abstr. 1970, 72, 110817r.
48. Fujita, I.; Tamura, Y.; Tani, H. ω-Formyl valerates. Japan Patent 70 72,338; Chem. Abstr. 1970, 72, 110817r.
49. Leo, A. J. Methods of calculating partition coefficients. In Comprehensive Medicinal Chemistry; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: Oxford, 1990; Vol. 4, pp 295-319.
50. Takahashi, I.; Terashima, S. Studies on the synthesis of 4-[1,8-dioxygenated-9,10-dioxoanthracen(or anthracen)-2-yl]butanoic acid derivatives. Chem. Pharm. Bull. 1982, 30, 4539-4544.